In GBM, p53 is frequently downregulated or inactivated by mutations leading to a reduction in apoptosis induction (Figure 2A) (65) and p53 inactivation positively correlates with GBM tumor invasiveness (66). This evidence concerns the gene TP53 and glioblastoma.